News

At the point of writing, we’ve got only 2 full days to enjoy Unity’s ‘Buy 1 Get 1’ deals. We’re looking at 1+1 multivitamins, dietary supplements, detox enzyme drinks, and more! 🤩 Their promotion ...
The FDA approved aceclidine 1.44% ophthalmic solution (Vizz) for adults with presbyopia, or age-related blurred near vision, ...
LENZ Therapeutics' VIZZ earns FDA approval as the first aceclidine-based eye drop to treat presbyopia, with U.S. launch expected in Q4 2025.
Aceclidine is a cholinergic muscarinic agonist that causes contraction of the iris sphincter muscle, thereby creating a pinhole effect that extends focus depth to improve vision in presbyopia.
The FDA has approved VIZZ, a once-daily, preservative-free eye drop that improves near vision in adults with presbyopia for up to 10 hours.
Small doses of the involuntary nervous system blocker, atropine, may offer a non-invasive treatment for symptomatic vitreous ...
The FDA approved Vizz for the treatment of presbyopia in adults, according to a press release from Lenz ...
The starting point for assessing NCD risk is its credit rating. All NCD issuers are rated by Sebi-accredited rating agencies, such as CRISIL, ICRA, and CARE. These ratings range from AAA (highest ...